About

Acceptance Rate:
14%
Time to first decision with review:
53 days*
Impact Factor:
9
Impact Factor rank (JCR):
7/100
Citescore:
16.1
Total Altmetric mentions:
2,833

Aims and scope

Thorax is one of the world's leading respiratory medicine journals, publishing clinical and experimental research articles on respiratory medicine, critical care, paediatrics, immunology, pharmacology, pathology, and surgery. Thorax seeks to publish significant advances in scientific understanding, which are likely to impact on clinical practice. This includes articles concerning basic and translational mechanisms with application to clinical material (cell and molecular biology, genetics, epidemiology, and immunology).
Thorax is BMJ's flagship respiratory medicine journal and has an open access companion journal, BMJ Open Respiratory Research. For information about the Thorax editorial team and the joint Editors-in-Chief (Mark Griffiths, Cecilia O'Kane & Jennifer Quint), please refer to the Editorial Board page.

Plan S compliance

Thorax is a Plan S compliant Transformative Journal. Transformative Journals are one of the compliance routes offered by cOAlition S funders, such as Wellcome, WHO and UKRI. Find out more about Transformative Journals and  Plan S compliance on our Author Hub.

Journal information

Ownership
Thorax is co-owned by the British Thoracic Society and BMJ
Publication Model
Subscription; with hybrid open access option
Frequency
Monthly
Launch date
1946
Digital Archives
Indexed by
Web of Science Core Collection: Science Citation Index, Science Citation Index Expanded; BIOSIS Reviews, Current Contents: Clinical Medicine, Life Sciences; MEDLINE (Index Medicus), PubMed Central (BMJ Open Access Special Collection), Scopus, Embase (Excerpta Medica), CINAHL, Google Scholar
Peer review model
Single anonymised; the names of reviewers are hidden from the author
Print ISSN
0040-6376
Online ISSN
1468-3296

Journal Statistics 2023

Acceptance rate: 14%
Speed Time to first decision without review (median): 2 days Time to first decision with review (median) : 53 days Time from acceptance to publication (median): 27 days
Impact Impact Factor category: Respiratory System Impact Factor (JCR): 9 Impact Factor rank: 7/100 5 Year Impact Factor: 8.4 Journal Citation Indicator: 2.17 Eigenfactor Score: 0.01958 Citescore: 16.1 Citescore rank: 6/155 SciMago Journal Rank (SJR): 3.001
Reach Total content views: 1.44 million Total Altmetric mentions: 2,833
sf_dora logo
The impact that academic research has cannot be defined by one single metric. In 2013, BMJ signed the San Francisco Declaration on Research Assessment (DORA). We did this to show our support for using multiple measures and metrics to portray journals’ impact; moving away from the Impact Factor as a single measure. How we get these metrics

Contact information

For all contact information please refer to the Contact Us page.

For authors

Please refer to the Instructions for Authors.

Affiliations

BTS logo
Thorax is provided as a benefit to members of the British Thoracic Society (BTS).
COPE logo
BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
Equator
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting accurate, transparent reporting of research studies. The BMJ Group is a sponsor of its activities.
AllTrials logo
BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.